![]() |
市场调查报告书
商品编码
1964070
鼻窦扩张器市场-全球产业规模、份额、趋势、机会、预测:按产品类型、最终用户、地区和竞争对手划分,2021-2031年Sinus Dilation Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By End user, By Region & Competition, 2021-2031F |
||||||
全球鼻窦扩张器市场预计将从 2025 年的 28.1 亿美元成长到 2031 年的 38.4 亿美元,复合年增长率为 5.35%。
这些设备主要包括球囊式鼻窦扩张系统和鼻窦支架,是专门用于扩张阻塞的鼻窦通道、恢復慢性鼻窦炎患者自然引流功能的医疗设备。与功能性内视镜鼻窦手术不同,这些方案无需切除大量组织即可机械性扩张鼻腔。市场成长趋势的根本驱动力是慢性呼吸系统疾病发病率的上升以及患者对微创门诊手术(可缩短復原时间)日益增长的偏好。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 28.1亿美元 |
| 市场规模:2031年 | 38.4亿美元 |
| 复合年增长率:2026-2031年 | 5.35% |
| 成长最快的细分市场 | 球囊鼻窦成形术系统 |
| 最大的市场 | 北美洲 |
然而,由于先进扩张手术的高成本以及新兴市场对医疗设备认证的严格监管要求,该市场面临巨大的阻力。儘管需要治疗的人群不断增长,但这些经济和官僚障碍限制了治疗的可近性。根据美国耳鼻喉头颈外科学会基金会预测,到2025年,美国成年人中将有11.6%患有慢性鼻窦炎,预计每年将导致约410万次门诊就诊。这些数据凸显了不断增长的临床需求与财务和监管挑战所带来的限制之间的差距。
全球慢性鼻窦炎 (CRS) 盛行率的上升是鼻窦扩张器材市场扩张的主要驱动因素。环境因素和人口老化导致全球感染率上升,进而增加了对球囊鼻窦成形术等有效外科手术介入的需求。日益增长的患者负担强烈表明,除了标准药物治疗外,还需要更多可扩展的治疗方法,从而扩大了适合机械扩张的患者群体。美国国立卫生研究院 (NIH) 于 2024 年 11 月进行的一项系统性回顾发现,全球 CRS 的总盛行率为 8.71%,凸显了鼻窦阻塞患者群体的庞大规模。
同时,由于市场正朝着更经济高效的门诊手术方向发生重大转变,医疗市场也正在经历重大变革。健康保险公司和医疗服务提供者越来越重视在门诊进行的微创技术,与手术室手术相比,这些技术能够显着降低成本。小型导航设备的出现也推动了这一趋势。 2024年9月发表在《Scholastica》杂誌上的一项研究表明,目前约有48.50%的球囊鼻窦成形术是在门诊进行的,这充分体现了治疗环境的转变。为了凸显这一趋势的商业性影响,Smith+Nephew公司在2025年2月发布的报告显示,其耳鼻喉科业务部门在第四季度实现了19.4%的潜在收入增长,这主要得益于手术量的回升。
与先进扩张手术相关的高昂费用是全球鼻窦扩张器械市场的主要阻碍因素。这项经济障碍显着限制了病患的就医途径,尤其是在健保报销模式不足以覆盖一次性球囊导管和支架系统高昂成本的地区。当经济负担转嫁给医疗服务提供者或患者需要自付高额费用时,这些微创手术的普及往往会被延迟,迫使患者依赖成本较低的传统手术。
此外,保险报销结构的改变也为诊所鼻窦手术的经济可行性带来了额外压力。据美国耳鼻喉头颈外科学会称,美国医疗保险和医疗补助服务中心已承诺在2024年将转换係数降低约3.37%,这将有效降低医生服务的支付水准。财政支持的减少使得医疗机构不愿储备昂贵的扩张装置,导致整体采购量下降,儘管这些技术具有明显的临床优势,但市场成长却受到阻碍。
人工智慧增强型手术导引系统的整合正在从根本上改变手术环境,显着提升复杂鼻窦手术的精确度。外科医师正在即时运用扩增实境(AR)迭加技术和机器学习演算法,大幅降低功能性内视镜鼻窦手术(FESS)中眼眶和颅底相关併发症的风险。这种技术融合使得在畸形解剖结构内进行安全导航成为可能,并推动了电动导航主机在门诊和住院环境中的应用。对这些技术的强劲需求也体现在行业业绩上:史赛克公司报告称,其外科和神经技术部门2025年10月的净销售额增长了14.4%,达到38亿美元,凸显了先进导航解决方案的快速普及。
同时,混合式鼻窦扩张术的应用日益广泛,该技术结合了球囊扩张术的组织保护效果和传统组织切除术的整体性。这项技术利用电动器材切除顽固性息肉和筛窦隔膜,同时扩张主要鼻窦开口,从而克服了单一扩张术的局限性,确保了广泛病变患者的通畅性。这一趋势推动了对能够同时支援电动切除和机械扩张的多功能手术平台的持续需求。为了佐证这一增长,史密斯医疗(Smith & Nephew)2025年11月发布的报告显示,其运动医学和耳鼻喉科部门实现了5.1%的潜在收入增长,这主要得益于对这种综合鼻窦修復策略所需器械的强劲需求。
The Global Sinus Dilation Devices Market is projected to expand from USD 2.81 Billion in 2025 to USD 3.84 Billion by 2031, registering a CAGR of 5.35%. These devices, primarily consisting of balloon sinus dilation systems and sinus stents, are specialized medical instruments used to widen obstructed sinus pathways and restore natural drainage in patients with chronic rhinosinusitis. Unlike traditional functional endoscopic sinus surgery, these solutions mechanically expand nasal passages without requiring extensive tissue removal. The market's upward trajectory is fundamentally underpinned by the increasing incidence of chronic respiratory conditions and a growing preference for minimally invasive outpatient procedures that offer patients shorter recovery periods.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 2.81 Billion |
| Market Size 2031 | USD 3.84 Billion |
| CAGR 2026-2031 | 5.35% |
| Fastest Growing Segment | Balloon Sinuplasty System |
| Largest Market | North America |
However, the market faces significant headwinds due to the high costs of advanced dilation procedures and stringent regulatory requirements for device approval in emerging markets. These economic and bureaucratic barriers restrict accessibility, even as the population requiring treatment grows. According to the American Academy of Otolaryngology-Head and Neck Surgery Foundation, chronic rhinosinusitis is expected to affect 11.6% of adults in the United States in 2025, leading to approximately 4.1 million annual ambulatory visits. This data highlights the disparity between the growing clinical need and the limitations imposed by financial and regulatory challenges.
Market Driver
The escalating global prevalence of Chronic Rhinosinusitis (CRS) acts as the primary engine driving the expansion of the sinus dilation devices market. As environmental factors and aging populations contribute to rising infection rates worldwide, the demand for effective surgical interventions, such as balloon sinuplasty, is intensifying. This increasing patient burden creates a critical need for scalable treatment options beyond standard medical management, thereby expanding the population eligible for mechanical dilation. According to a systematic review by the National Institutes of Health (NIH) in November 2024, the global pooled prevalence of CRS was identified at 8.71%, underscoring the massive scale of the population suffering from sinonasal obstruction.
Concurrently, the market is undergoing a significant transformation due to a decisive shift toward cost-effective office-based procedures. Healthcare payers and providers are increasingly prioritizing minimally invasive techniques performed in outpatient settings, which significantly lower costs compared to operating room surgeries, a trend supported by the advent of compact, navigation-enabled devices. A study published via Scholastica in September 2024 noted that approximately 48.50% of balloon sinuplasty cases are now conducted in office settings, illustrating this migration of care. Highlighting the commercial impact of this trend, Smith+Nephew reported in February 2025 that their ENT business segment achieved 19.4% underlying revenue growth in the fourth quarter, fueled by recovering procedure volumes.
Market Challenge
The substantial expense linked to advanced dilation procedures represents a major constraint on the global sinus dilation devices market. This financial obstacle severely limits patient access, especially in regions where reimbursement models fail to adequately cover the premium costs of single-use balloon catheters and stent systems. When the financial burden is shifted to healthcare providers or necessitates high out-of-pocket payments from patients, the adoption of these minimally invasive interventions slows, often compelling a reliance on less expensive, traditional surgical options.
Moreover, evolving reimbursement structures are placing additional pressure on the economic viability of office-based sinus procedures. According to the American Academy of Otolaryngology-Head and Neck Surgery, the Centers for Medicare & Medicaid Services finalized a conversion factor reduction of roughly 3.37 percent in 2024, effectively lowering payment rates for physician services. This decrease in financial support deters medical practices from maintaining expensive inventories of dilation devices, thereby curtailing overall procurement volumes and hindering market growth despite the clear clinical advantages of these technologies.
Market Trends
The integration of AI-augmented surgical navigation systems is fundamentally transforming the procedural environment by improving precision during complex sinus interventions. Surgeons are increasingly adopting augmented reality (AR) overlays and machine learning algorithms to map drainage pathways in real-time, which significantly mitigates the risk of complications involving the orbit or skull base during functional endoscopic sinus surgery (FESS). This technological convergence facilitates safer navigation through distorted anatomies, driving the adoption of powered navigation consoles in both ambulatory and hospital settings. The strong demand for these technologies is reflected in industry performance; Stryker reported in October 2025 that its MedSurg and Neurotechnology segment grew net sales by 14.4% to reach $3.8 billion, highlighting the rapid uptake of advanced navigation solutions.
Simultaneously, there is a rising adoption of hybrid sinus dilation techniques that merge the tissue-preservation advantages of balloon sinuplasty with the comprehensive nature of traditional tissue removal. This approach resolves the limitations of standalone dilation by utilizing powered instruments to eliminate resistant polyps or ethmoid partitions while dilating major sinus ostia, ensuring lasting patency for patients with extensive disease. This trend fosters sustained demand for versatile surgical platforms capable of supporting both powered resection and mechanical dilation. Validating this growth, Smith+Nephew's November 2025 report indicated that their Sports Medicine & ENT unit achieved 5.1% underlying revenue growth, driven by the resilient consumption of instruments essential for these comprehensive sinus repair strategies.
Report Scope
In this report, the Global Sinus Dilation Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Sinus Dilation Devices Market.
Global Sinus Dilation Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: